Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of RNA Editing in Cancer Development and Metabolic Disorders
Che-Pei Kung, Leonard B. Maggi, Jason D. Weber
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer
Tin Lok Wong, Jia-Jian Loh, Shi‐Xun Lu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells
Kyle A. Cottrell, Sua Ryu, Jackson R. Pierce, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 4, pp. 986-1003
Open Access | Times Cited: 15
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications
Juan Carrillo-Reixach, Laura Torrens, Marina Simon‐Coma, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 328-341
Open Access | Times Cited: 106
Zika virus noncoding sfRNAs sequester multiple host-derived RNA-binding proteins and modulate mRNA decay and splicing during infection
Daniel Michalski, J. Gustavo Ontiveros, Joseph Russo, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 44, pp. 16282-16296
Open Access | Times Cited: 76
Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer
Che-Pei Kung, Kyle A. Cottrell, Sua Ryu, et al.
Oncogene (2020) Vol. 40, Iss. 1, pp. 189-202
Open Access | Times Cited: 76
Nonsense suppression therapies in human genetic diseases
Patrícia Martins-Dias, Luı́sa Romão
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 10, pp. 4677-4701
Closed Access | Times Cited: 59
RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS
Reshma Raghava Kurup, Eimile Oakes, Aidan C. Manning, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 9, pp. 102267-102267
Open Access | Times Cited: 43
RNA Editing Analysis Reveals Methyl Jasmonic Acid Regulation of Fucoxanthin and Fatty Acid Metabolism in Phaeodactylum tricornutum
Shu Huang, Hao Liu, Ruihao Xu, et al.
Marine Drugs (2025) Vol. 23, Iss. 2, pp. 66-66
Open Access | Times Cited: 1
ADAR Family Proteins: A Structural Review
Carolyn Ashley, Emmanuel Broni, Whelton A. Miller
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 3919-3945
Open Access | Times Cited: 7
APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival
Mariko Asaoka, Takashi Ishikawa, Kazuaki Takabe, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5621-5621
Open Access | Times Cited: 54
Inhibiting DNA methylation and RNA editing upregulates immunogenic RNA to transform the tumor microenvironment and prolong survival in ovarian cancer
Stephanie Gomez, Olivia L. Cox, Reddick R. Walker, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e004974-e004974
Open Access | Times Cited: 23
Selective Inhibition of ADAR1 Using 8-Azanebularine-Modified RNA Duplexes
Herra G. Mendoza, Victorio Jauregui Matos, SeHee Park, et al.
Biochemistry (2023) Vol. 62, Iss. 8, pp. 1376-1387
Open Access | Times Cited: 15
The cellular and KSHV A-to-I RNA editome in primary effusion lymphoma and its role in the viral lifecycle
Suba Rajendren, Xiang Ye, William Dunker, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 14
RNA editing in cancer impacts mRNA abundance in immune response pathways
Tracey W. Chan, Ting Fu, Jae Hoon Bahn, et al.
Genome biology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 35
A-to-I RNA Editing in Cancer: From Evaluating the Editing Level to Exploring the Editing Effects
Heming Wang, Sinuo Chen, Jiayi Wei, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 29
RNA modifications as emerging therapeutic targets
Akın Çayır
Wiley Interdisciplinary Reviews - RNA (2021) Vol. 13, Iss. 4
Closed Access | Times Cited: 27
Inosine and its methyl derivatives: Occurrence, biogenesis, and function in RNA
Nivedita Dutta, Indrajit Deb, Joanna Sarzyńska, et al.
Progress in Biophysics and Molecular Biology (2022) Vol. 169-170, pp. 21-52
Closed Access | Times Cited: 20
RNA Editing in Cancer Progression
Valentina Frezza, Lidia Chellini, Arianna Del Verme, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5277-5277
Open Access | Times Cited: 12
A‐to‐I RNA editing by ADAR and its therapeutic applications: From viral infections to cancer immunotherapy
Rohini Datta, Julia Z. Adamska, Amruta Bhate, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Closed Access | Times Cited: 11
ADAR1 Regulates Lipid Remodeling through MDM2 to Dictate Ferroptosis Sensitivity
Che-Pei Kung, Nick D. Terzich, Ma Xenia G. Ilagen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Exploring genome-transcriptome correlations in cancer
Michael Ronemus, Daniel W. Bradford, Zvi Laster, et al.
Biochemical Society Transactions (2025) Vol. 53, Iss. 01
Closed Access
BIRC3 RNA Editing Modulates Lipopolysaccharide-Induced Liver Inflammation: Potential Implications for Animal Health
Wangchang Li, Duming Cao, Minghua Shi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2941-2941
Open Access
A novel mechanism for A-to-I RNA-edited CYP1A1 in promoting cancer progression in NSCLC
Zhipeng Wang, Yan Wu, Ziqi Ding, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
A Census and Categorization Method of Epitranscriptomic Marks
Julia Mathlin, Loredana Le Pera, Teresa Colombo
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4684-4684
Open Access | Times Cited: 31
A mark of disease: how mRNA modifications shape genetic and acquired pathologies
Eliana Destefanis, Gülben Avşar, P Groza, et al.
RNA (2020) Vol. 27, Iss. 4, pp. 367-389
Open Access | Times Cited: 30
Page 1 - Next Page

Scroll to top